A prospective cohort study is conducted to evaluate the association between the regular use of a novel synthetic oral glucocorticoid and the development of avascular necrosis (AVN) of the femoral head. The study follows patients prescribed the new glucocorticoid and patients prescribed standard nonsteroidal anti-inflammatory drugs (NSAIDs) for similar rheumatologic conditions. Over a -year follow-up period, patients in the glucocorticoid group and patients in the NSAID group develop AVN.
Based on these findings, what percentage of the AVN cases in the glucocorticoid group is theoretically attributable to the use of the new drug?
Answer: 75 %
Answer
75
The correct answer is . The Attributable Risk Percent (ARP) represents the fraction of disease in the exposed group that is directly attributable to the exposure. It is calculated as . In this study, the incidence in the exposed (glucocorticoid) group is . The incidence in the unexposed (NSAID) group is . Therefore, . Alternatively, this can be calculated using Relative Risk (RR). . .
Step-by-Step Solution
Key Concept
Attributable Risk Percent (ARP) measures the proportion of disease in an exposed group that is directly attributable to the exposure, calculated as or .